A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Emerging Tech Rapid genomic profiling of colon cancers can improve therapy selection for patients June 30, 2020 Genomic mutation testing is critical to therapeutic selection and management of patients with colorectal cancer.…